Results 21 to 30 of about 386 (142)

Features of external therapy of allergic skin diseases in children

Медицинский совет, 2022
The development of inflammatory process in the skin has proven to be primarily associated with the immune system defects, in particular T-lymphocytes: the Th2 response predominates during the acute phase of the disease, when Th2 cells are stimulated with
I. N. Kholodova
doaj   +1 more source

Lichen Planus Due to Hirudotherapy

Türkiye Parazitoloji Dergisi, 2021
Lichen planus is a traumatic (koebner positive), chronic, inflammatory and autoimmune disease affecting the oral and genital mucosa, scalp and nails.
Munise Daye, Begüm Işık, Fahriye Kılınç   +2 more
doaj   +1 more source

External therapy of atopic dermatitis in children

Медицинский совет, 2013
The article reviews scientific literature and provides own results of phased application of methylprednisolone aceponate (Advantan, BAYER) and Dardia products in the multimodal treatment of children with atopic dermatitis. The effectiveness and safety of
I. V. Khamaganova, D. F. Kashevarov
doaj   +1 more source

Evidence- and consensus-based guideline on lichen sclerosus. [PDF]

J Dtsch Dermatol Ges
Summary The German‐language, consensus‐ and evidence‐based S3 guideline on lichen sclerosus (LS) was developed based on the European “EuroGuiDerm Guideline on lichen sclerosus” under the leadership of the German Dermatological Society (DDG) and the German Society for Gynecology and Obstetrics (DGGG).
Kirtschig G, Woelber L, Günthert A, Becker K, Ciresa-König A, Fischer B, Fricke-Otto S, Günther C, Hirchenhain C, Köllmann NH, Kreuter A, Malisiewicz B, Neis F, Mon O'Dey D, Ott H, Promm M, Renner R, Schardt AR, Schweizer I, Stein R, Ter-Nedden J, Trutnovsky G, Wand A, Weyandt G, Werner RN, Kinberger M.   +25 more
europepmc   +2 more sources

Experience of application 0.1% methylprednisolone aceponatе in a complex therapy chronic dermatoses

Vestnik Dermatologii i Venerologii, 2017
The review describes the structure and pharmacokinetics of 0.1% methylprednisolone aceponate, world’s data practice, showing high efficiency and safety of this drug in the treatment of chronic dermatoses, presents the results of study the therapeutic ...
Y. S. Kondratyeva, V. V. Karchova
doaj   +1 more source

ATOPIC MARCHE. POSSIBILITIES OF THERAPY OF ATOPIC DERMATITIS IN CHILDREN OF EARLY AGE

Медицинский совет, 2017
The article provides a justification of use of topical corticosteroids in therapy of atopic dermatitis (AtD) in infants and young children. The results of application of 0.1% of methylprednisolone aceponate in AtD children confirm high effectiveness ...
N. M. Sharova
doaj   +1 more source

Modern Outlooks on «Atopic March» Secondary Prevention Capabilities in Children with Atopic Dermatitis

Вопросы современной педиатрии, 2020
Atopic dermatitis (AD) is one of the most common inflammatory diseases of childhood, and it is the first one in gradual development of allergic diseases, also known as «atopic march».
Nikolay N. Murashkin, Leyla S. Namazova-Baranova, Roman A. Ivanov, Dmitri V. Fedorov, Eduard T. Ambarchian, Alena A. Savelova, Roman V. Epishev, Alexander I. Materikin, Leonid A. Opryatin   +8 more
doaj   +1 more source

CHRONIC ITCHING DERMATOSIS IN CHILDREN: MODERN METHODS OF TREATMENT AND EFFICIENT TERMINATION OF SUBJECTIVE COMPLAINTS

Педиатрическая фармакология, 2016
The article presents contemporary data on the peculiarities of etiology and pathogenesis of chronic itching dermatosis in children. We provide classification of various itching forms and pathophysiological mechanism of the development thereof underlying ...
N. N. Murashkin, E. T. Ambarchyan, A. I. Materikin, R. V. Epishev   +3 more
doaj   +1 more source

Combined pathogenetic therapy of allergic dermatoses in children

Медицинский совет, 2021
Allergodermatoses make up the majority of allergic skin diseases in childhood, have a recurrent course and significantly disrupt the quality of life of patients and their families. The constant use of emollients, allowing to lengthen periods of remission
J. S. Kovaleva, N. K. Zyablitskaya, M. V. Orobei, N. K. Bishevskaya   +3 more
doaj   +1 more source

Analysis of the list and availability of medicines used for the treatment of atopic dermatitis in Ukraine

Фармацевтичний журнал, 2022
The prevalence of atopic dermatitis (AD) is growing rapidly among the population, treatment protocols need to be reviewed, taking into account evidence-based medicine data and the introduction of new drugs and new forms in the country's market.
O. M. Zaliska, N. M. Maksymovych, Z. O. Zabolotnya, B. M. Zalisky   +3 more
doaj   +1 more source